Merck spins off slow-growing drugs into US$ 6.5 billion firm; Aurobindo’s facility gets classified as OAI
This week, Phispers brings you news on Merck as the drugmaker spun off its slowing-growing drugs into a new drug company with U...
Impressions : 3504
Gilead loses patent case to Bristol-Myers over its CAR-T therapy; Amneal beats Dr. Reddy’s on key generic approval
This week, Phispers brings you news on Bristol-Myers Squibb winning a patent case against Gilead’s Yescarta — a US$...
Impressions : 1957
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.